IntrinsicIntrinsic
← Scroll for more →

Financial Statements — GHRS

Balance Sheet

(in millions USD)
MetricQ4 2025Q3 2025Q1 2025Q4 2024Q3 2024Q1 2024Q4 2023Q3 2023Q1 2023Q4 2022Q3 2022Q4 2021
Cash & Equivalents246.25249.65244.95100.7990.0677.4878.4286.44105.08165.96256.94276.78
Total Current Assets285.98294.79294.67154.23154.95160.48164.09164.04--168.54--279.84
Total Non-current Assets2.257.2325.7934.0544.6757.1162.2168.53--85.82--0.08
Total Assets288.23302.02320.45188.27199.61217.58226.30232.57--254.36--279.92
Total Current Liabilities8.3810.419.928.959.797.286.706.13--4.55--2.75
Total Non-current Liabilities*0.150.220.320.370.460.560.630.66--0.00--0.00
Total Liabilities8.5310.6310.249.3210.257.847.336.80--4.55--2.75
Retained Earnings(154.43)(140.29)(117.04)(106.45)(97.64)(75.51)(67.94)(56.67)--(32.49)--(10.04)
Total Stockholder Equity279.70291.40310.21178.95189.37209.75218.97225.77241.83249.82256.74277.18
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022
Research & Development10.578.967.858.409.768.667.097.187.314.624.24
Selling, General & Admin6.005.754.884.223.462.872.632.753.112.012.51
Total Operating Expenses16.5714.7012.7312.6213.2211.539.729.9310.426.636.75
Operating Income(16.57)(14.70)(12.73)(12.62)(13.22)(11.53)(9.72)(9.93)(10.42)(6.63)(6.75)
Pretax Income(14.02)(9.29)(10.81)(12.11)(10.38)(7.67)(5.65)(7.73)(10.94)(0.44)0.33
Tax Provision0.000.000.000.000.000.000.000.000.000.000.00
Net Income(14.02)(9.29)(10.81)(12.11)(10.38)(7.67)(5.65)(7.73)(10.94)(0.44)0.33
Basic EPS(0.23)(0.15)(0.19)(0.23)(0.20)(0.15)(0.11)(0.15)(0.21)(0.01)0.01
Diluted EPS(0.23)(0.15)(0.19)(0.23)(0.20)(0.15)(0.11)(0.15)(0.21)(0.01)0.01
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ1 2025Q1 2024Q1 2023
Operating Cash Flow(8.57)(9.60)(6.88)
Investing Cash Flow11.848.79(54.02)
Financing Cash Flow140.86(0.07)--
← Scroll for more columns →